ELV · Elevance Health Inc.
$395.182026-07-21Sector: Healthcare; Industry: Medical - Healthcare Plans; Sub-Industry: Managed Health Care
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$0
-2268.6% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($-4941 · $676) Analysts Range ($331 · $498) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $171.3B | — | 5.1% | 22.4% | $6.8B | −$6.3B | $516MM | 7.0% | — | 11.2% | $60.8B | $27.16 | — |
| 2024.Q4 | $171.3B | 0.0% | 5.1% | 24.5% | $6.6B | −$6.0B | $578MM | 6.5% | — | 10.5% | $65.1B | $27.16 | — |
| 2025.Q1 | $176.8B | 3.2% | 5.0% | 23.9% | $6.8B | −$5.6B | $1.2B | 7.4% | — | 10.4% | $65.0B | $27.13 | — |
| 2025.Q4 | $176.8B | 0.0% | 5.0% | 15.6% | $7.5B | −$2.8B | $4.7B | 6.4% | — | 11.4% | $67.1B | $27.13 | — |
| 2026.Q1 | $200.4B | 13.4% | 3.8% | 15.8% | $6.4B | $25MM | $6.5B | 6.7% | — | 12.0% | $40.2B | $23.79 | 11.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.6% |
| 2027.Q1 | $196.2B | +-2.1% | 4.1% | 16.2% | $6.7B | $0MM | $6.7B | 7.5% | $6.3B | 16.7% | $40.2B | $30.48 | 13.0 |
| 2028.Q1 | $202.3B | +3.1% | 4.1% | 16.6% | $6.9B | −$71MM | $6.8B | 7.6% | $5.9B | 17.1% | $40.3B | $31.27 | 12.6 |
| 2029.Q1 | $212.9B | +5.2% | 4.1% | 17.0% | $7.2B | −$230MM | $7.0B | 7.7% | $5.6B | 17.9% | $40.5B | $32.73 | 12.1 |
| 2030.Q1 | $225.4B | +5.9% | 4.1% | 17.5% | $7.6B | $0MM | $7.6B | 7.8% | $5.7B | 18.8% | $40.5B | $34.48 | 11.5 |
| 2031.Q1 | $241.8B | +7.3% | 4.1% | 17.9% | $8.1B | $0MM | $8.1B | 7.9% | $5.6B | 20.0% | $40.5B | $36.79 | 10.7 |
|
| Term. Yr+ | $326.9B | 4.1% | 3.3% | 20.0% | $8.7B | −$4.1B | $4.5B | 8.6% | $46.9B | 8.6% | — | — | — |
Active scenario IV: $0 (-2268.6% vs market)